Skip to main content
Clinical Trials/IRCT20210920052524N1
IRCT20210920052524N1
Recruiting
Phase 1

Study of safety and efficacy of transplantation of platelet extracted mitochondria in heart ischemic stroke, Clinical trial phase 1 and 2

Rasht University of Medical Sciences0 sites34 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasht University of Medical Sciences
Enrollment
34
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Participants, their close relatives or lawyers are able to sign a consent form;
  • Patients with recent myocardial ischemia within 24 hours
  • Candidate for interventional treatment.
  • Ejection fraction less than or equal to 41% (EF \= 41%).
  • The age range is between 45\-70 years
  • Both Genders

Exclusion Criteria

  • Patients with mitochondrial disorders.
  • Patients with diabetes
  • Patients with renal failure.
  • Pregnant women
  • Patients with cancer are not included in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials